The benefit of ________ for the treatment of thrombosis is that it is clot-specific,thereby reducing the risk of generalised haemorrhage.

Question

Quizplus · Accepted Answer

Tissue plasminogen activator (tPA) has the benefit of being clot-specific, meaning it only targets the clot and not other parts of the body that may not need to be dissolved. This reduces the risk of generalised haemorrhage, which is a potential complication with other thrombolytic agents such as urokinase and streptokinase. Warfarin, on the other hand, is an anticoagulant and not a thrombolytic agent, and its benefit is mainly in preventing the formation of new clots rather than dissolving existing ones.

The Benefit of ________ for the Treatment of Thrombosis Is